TR201105367A2 - Akış özellikleri geliştirilmiş bir kuru toz formülasyonu. - Google Patents

Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Info

Publication number
TR201105367A2
TR201105367A2 TR2011/05367A TR201105367A TR201105367A2 TR 201105367 A2 TR201105367 A2 TR 201105367A2 TR 2011/05367 A TR2011/05367 A TR 2011/05367A TR 201105367 A TR201105367 A TR 201105367A TR 201105367 A2 TR201105367 A2 TR 201105367A2
Authority
TR
Turkey
Prior art keywords
dry powder
powder formulation
flow properties
improved flow
present
Prior art date
Application number
TR2011/05367A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/05367A priority Critical patent/TR201105367A2/tr
Priority to TR2012/05852A priority patent/TR201205852A2/tr
Priority to PCT/TR2012/000091 priority patent/WO2012166070A1/en
Priority to PCT/TR2012/000096 priority patent/WO2013009271A1/en
Publication of TR201105367A2 publication Critical patent/TR201105367A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; astım ve KOAH gibi solunum yolları hastalıklarında kullanılmak üzere geliştirilmiş yeni bir kuru toz formülasyon ile ilgilidir.
TR2011/05367A 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu. TR201105367A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR2012/05852A TR201205852A2 (tr) 2011-06-02 2012-05-21 Geliştirilmiş yeni kuru toz formülasyonu.
PCT/TR2012/000091 WO2012166070A1 (en) 2011-06-02 2012-05-28 Dry powder formulation with improved flow characteristics
PCT/TR2012/000096 WO2013009271A1 (en) 2011-06-02 2012-05-31 New improved dry powder formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Publications (1)

Publication Number Publication Date
TR201105367A2 true TR201105367A2 (tr) 2012-12-21

Family

ID=46456987

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/05367A TR201105367A2 (tr) 2011-06-02 2011-06-02 Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.

Country Status (2)

Country Link
TR (1) TR201105367A2 (tr)
WO (1) WO2012166070A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
EP3823602A4 (en) * 2018-07-20 2022-04-27 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi INHALATION COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS
IT201900002857A1 (it) * 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0219513D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
WO2011136753A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
JP2013529606A (ja) * 2010-06-22 2013-07-22 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 抗ムスカリン薬含有乾燥粉末配合物

Also Published As

Publication number Publication date
WO2012166070A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
PL2892808T3 (pl) Kruszywa stabilizowane oraz inne materiały i konstrukcje przeznaczone do pochłaniania energii, lecz nie ograniczające się do tego
FR3000095B1 (fr) Composition comprenant du 2,3,3,3-tetrafluoropropene et du 1,2-difluoroethylene
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
HRP20181551T1 (hr) Stabilan pripravak stlačene aerosolne otopine kombinacije glikopironijeva bromida i formoterola
EP2921183A4 (en) AIR CLEANER
HUE049171T2 (hu) Rák diagnózisban felhasználható Claudin 18.2 elleni antitestek
TWD160007S (zh) 車輛引擎蓋（一）
CL2014002037A1 (es) Material mineral en polvo con elevada capacidad de dispersión, y uso de dicho material mineral en polvo
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
CO6950497A2 (es) Compuestos de 1,2,5-oxadiazol sustituidos y su uso como herbicidas
EP2746394A4 (en) ANTIBODY AND ANTIBODY COMPOSITION
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
JP2015513329A5 (ja) 手指衛生順守の決定方法
BR112014005406A2 (pt) composição de vacina e respectivo uso
BR112014017481A2 (pt) formulação em pó seco para uso em um inalador de pó seco, inalador de pó seco e uso de uma formulação
BR112014020992A2 (pt) Composto,uso de composto na fabricação de um medicamento e composição farmacêutica
AR092882A1 (es) 1,2,4-triazin-3,5-dion-6-carboxamidas y su uso como herbicidas
TWD169341S (zh) 用於空氣清淨機之片狀材料之部分
TR201109439A2 (tr) Pompa içeren inhalasyon cihazı.
DE112012000297A5 (de) Filter, insbesondere Atemluftfilter
TR201205852A2 (tr) Geliştirilmiş yeni kuru toz formülasyonu.
PL2617086T3 (pl) Akumulator, skrzynka akumulatora i sposób wytwarzania akumulatora
TR201100148A2 (tr) Stabil akarboz förmülasyonları.
TR201105367A2 (tr) Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
IN2013CH01374A (tr)